Please Find enclosed herewith the Outcome of the Board Meeting dated 08/12/2025 for your reference.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Genomic Valley Biotech Ltd, at its meeting on December 8, 2025, approved convening the 31st Annual General Meeting on December 31, 2025, at 09:00 AM at the registered office in Jhajjar, Haryana. The Board also approved the AGM Notice and Director's Report for the financial year ended March 31, 2025, appointed M/s SBR & Co. LLP as Scrutinizer, and set December 24, 2025 as the cut-off date for e-voting eligibility. The Register of Members and Share Transfer Books will remain closed from December 25 to December 31, 2025. Additionally, the Board recommended an alteration in the Object Clause of the Memorandum of Association to expand the company's business scope into DNA/RNA equipment, biotechnology research, bioinformatics tools, and related areas.
Shareholders should note the book closure period (Dec 25–31, 2025) during which no share transfers will be registered, and the cut-off date of Dec 24, 2025 for e-voting eligibility. The proposed expansion of the Object Clause could open new revenue streams in biotech, genomics, and AI-driven healthcare, but requires shareholder approval at the AGM.